http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Optimizerx Corporation (OPRX) Names Edward Stelmakh as CFO and COO
-
OptimizeRx Appoints Seasoned Financial and Operational Executive, Edward Stelmakh as Chief Financial Officer and Chief Operations Officer
-
OptimizeRx Appoints Seasoned Financial and Operational Executive, Edward Stelmakh as Chief Financial Officer and Chief Operations Officer
-
OptimizeRx Survey Demonstrates Value of Digital Solutions in Addressing Unmet Patient and Provider Needs in Diabetes
-
OptimizeRx Survey Demonstrates Value of Digital Solutions in Addressing Unmet Patient and Provider Needs in Diabetes
-
OptimizeRx Announces Significant Platform Enhancement to Digitize Pharmaceutical Access Solutions
-
OptimizeRx Announces Significant Platform Enhancement to Digitize Pharmaceutical Access Solutions
-
OptimizeRx Welcomes Andrew D’Silva as Senior Vice President of Corporate Finance
-
OptimizeRx Welcomes Andrew D’Silva as Senior Vice President of Corporate Finance
-
OptimizeRx Recognized as a Finalist in Questex’s Fierce Pharma Marketing Awards 2021
-
OptimizeRx Recognized as a Finalist in Questex’s Fierce Pharma Marketing Awards 2021
-
OptimizeRx to Present at Upcoming September Investor Conferences
-
OptimizeRx to Present at Upcoming September Investor Conferences
-
OptimizeRx and Demandbase Form Exclusive Account-Based-Experience (ABX) Partnership — Delivering Industry’s Most Powerful ABX Solution for Life Sciences
-
OptimizeRx and Demandbase Form Exclusive Account-Based-Experience (ABX) Partnership — Delivering Industry’s Most Powerful ABX Solution for Life Sciences
-
OptimizeRx Reports Second Quarter 2021 Financial Results, Revenue Up 55% as Leading Pharma Brands Aggressively Seek Improved ROI Through Technology Adoption
-
OptimizeRx Reports Second Quarter 2021 Financial Results, Revenue Up 55% as Leading Pharma Brands Aggressively Seek Improved ROI Through Technology Adoption
-
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET
-
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET
-
OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients
-
OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients
-
OptimizeRx Aligned With Pharma Across Fast Growing Specialty Therapeutic Areas
-
OptimizeRx Aligned With Pharma Across Fast Growing Specialty Therapeutic Areas
-
OptimizeRx Named to LD Micro’s “Hall of Fame” As One of the Top 50 Performing Companies
-
OptimizeRx Named to LD Micro’s “Hall of Fame” As One of the Top 50 Performing Companies
-
OptimizeRx to Participate in the William Blair 41st Annual Growth Stock Conference
-
OptimizeRx to Participate in the William Blair 41st Annual Growth Stock Conference
-
OptimizeRx to Present at RBC Capital Markets Global Virtual Healthcare Conference on May 19, 2021
-
OptimizeRx to Present at RBC Capital Markets Global Virtual Healthcare Conference on May 19, 2021
-
OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital Health
-
OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital Health
-
OptimizeRx Expands Omni-channel Platform Reach at Point-Of-Care
-
OptimizeRx Expands Omni-channel Platform Reach at Point-Of-Care
-
OptimizeRx Named to Financial Times ―The Americas’ Fastest-Growing Companies List for the Second Consecutive Year
-
OptimizeRx Named to Financial Times ―The Americas’ Fastest-Growing Companies List for the Second Consecutive Year
-
OptimizeRx Recurring Revenue Grows as it Secures 19 New Enterprise-Level Engagements in Q1 2021
-
OptimizeRx Recurring Revenue Grows as it Secures 19 New Enterprise-Level Engagements in Q1 2021
-
OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
-
OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
-
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share
-
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share
-
OptimizeRx’s Angelo Campano Named to MM+M 40 Under 40 List
-
OptimizeRx’s Angelo Campano Named to MM+M 40 Under 40 List
-
OptimizeRx Expects Q4 2020 Revenue up 117% to Record $16 Million, Full Year up 75% to Record $43 Million
-
OptimizeRx Expects Q4 2020 Revenue up 117% to Record $16 Million, Full Year up 75% to Record $43 Million
-
OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021
-
OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021
-
OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021
-
OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021
-
OptimizeRx’s TelaRep™ Recognized as One of the Most Innovative Products for Life Sciences by PM360
